NEW YORK and AMSTERDAM, July 01, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (ATAI) (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company on a mission to develop highly effective mental ...

Atai Life Sciences founder Christian Angermayer says holding Bitcoin could be a way for biotech firms to survive the blisteringly long approval process required to bring their drugs to market.

Atai Life Sciences, a Germany-based biopharmaceutical company, has become the latest publicly traded firm to adopt a Bitcoin treasury strategy. The Nasdaq-listed company, chaired by entrepreneur ...

Atai Life Sciences announced a financing deal to raise approximately $50 million by selling 18,264,840 ordinary shares and pre-funded warrants to purchase an additional 4,566,210 shares. The funds ...

Atai Beckley NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and ...

NEW YORK and AMSTERDAM, Oct. 20, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (ATAI) (“atai”), a clinical-stage biopharmaceutical company focused on transforming the treatment of mental health ...

(RTTNews) - Atai Life Sciences N.V. (ATAI), a clinical-stage biopharmaceutical company, on Tuesday announced that it has entered into subscription agreements for the sale of 18,264,840 ordinary shares ...